Envestnet Asset Management Inc. Sells 51,936 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Envestnet Asset Management Inc. decreased its stake in shares of Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 77.1% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 15,430 shares of the medical instruments supplier's stock after selling 51,936 shares during the quarter. Envestnet Asset Management Inc. owned about 0.07% of Mettler-Toledo International worth $18,881,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in MTD. JPMorgan Chase & Co. increased its position in Mettler-Toledo International by 14.7% during the third quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier's stock worth $332,634,000 after acquiring an additional 28,478 shares during the period. M&T Bank Corp grew its holdings in shares of Mettler-Toledo International by 14.3% during the 3rd quarter. M&T Bank Corp now owns 4,926 shares of the medical instruments supplier's stock worth $7,387,000 after purchasing an additional 615 shares in the last quarter. Allworth Financial LP increased its holdings in Mettler-Toledo International by 367.4% in the 4th quarter. Allworth Financial LP now owns 215 shares of the medical instruments supplier's stock valued at $285,000 after buying an additional 169 shares during the period. Nordea Investment Management AB raised its position in Mettler-Toledo International by 29.8% during the fourth quarter. Nordea Investment Management AB now owns 105,823 shares of the medical instruments supplier's stock valued at $129,919,000 after purchasing an additional 24,285 shares in the last quarter. Finally, Robeco Institutional Asset Management B.V. raised its stake in Mettler-Toledo International by 18.0% during the fourth quarter. Robeco Institutional Asset Management B.V. now owns 34,370 shares of the medical instruments supplier's stock worth $42,058,000 after acquiring an additional 5,234 shares in the last quarter. 95.07% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts have commented on MTD shares. Citigroup upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 target price for the company in a research report on Monday, April 7th. Evercore ISI boosted their target price on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an "outperform" rating in a report on Monday, February 10th. Robert W. Baird raised their price target on shares of Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a "neutral" rating in a research note on Monday, February 10th. Finally, Wells Fargo & Company reduced their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,125.00 and set an "equal weight" rating on the stock in a research note on Thursday. One analyst has rated the stock with a sell rating, five have assigned a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, Mettler-Toledo International currently has a consensus rating of "Hold" and an average price target of $1,346.13.

Mettler-Toledo International Trading Down 1.2 %

Shares of MTD traded down $11.93 on Friday, reaching $1,004.72. The company's stock had a trading volume of 212,078 shares, compared to its average volume of 140,553. The stock has a market capitalization of $20.94 billion, a PE ratio of 24.79, a PEG ratio of 3.30 and a beta of 1.28. Mettler-Toledo International Inc. has a twelve month low of $946.69 and a twelve month high of $1,546.93. The firm has a fifty day moving average of $1,191.96 and a 200-day moving average of $1,264.86.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, topping analysts' consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. As a group, equities analysts anticipate that Mettler-Toledo International Inc. will post 42.71 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, insider Gerry Keller sold 600 shares of Mettler-Toledo International stock in a transaction on Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total value of $810,804.00. Following the transaction, the insider now owns 6 shares in the company, valued at $8,108.04. This trade represents a 99.01 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Christian Magloth sold 790 shares of the firm's stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the transaction, the insider now directly owns 734 shares in the company, valued at $964,248.46. This trade represents a 51.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.94% of the company's stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.